This funding supports comprehensive viral hepatitis programs including outbreak response, surveillance for hepatitis A, B, and C, strategic planning, partnerships, testing, treatment, and perinatal hepatitis C initiatives. Applicants must be U.S. state, territorial, or local health departments or their bona fide agents. The program aims to improve surveillance, reporting, and access to prevention and care services in high-impact settings.
Eligible applicants include state, county, city, and special district governments, as well as bona fide agents of state health departments and local health agencies in the U.S. and territories. Documentation of agent arrangements is required.
